DK0735890T3 - Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning - Google Patents
Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredningInfo
- Publication number
- DK0735890T3 DK0735890T3 DK95909917T DK95909917T DK0735890T3 DK 0735890 T3 DK0735890 T3 DK 0735890T3 DK 95909917 T DK95909917 T DK 95909917T DK 95909917 T DK95909917 T DK 95909917T DK 0735890 T3 DK0735890 T3 DK 0735890T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxycarbamide
- spread
- dideoxyinosine
- mixtures
- retrovirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/169,253 US5521161A (en) | 1993-12-20 | 1993-12-20 | Method of treating HIV in humans by administration of ddI and hydroxycarbamide |
PCT/IB1995/000153 WO1995017899A2 (en) | 1993-12-20 | 1994-12-20 | Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0735890T3 true DK0735890T3 (da) | 2002-08-05 |
Family
ID=22614846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95909917T DK0735890T3 (da) | 1993-12-20 | 1994-12-20 | Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning |
Country Status (13)
Country | Link |
---|---|
US (2) | US5521161A (da) |
EP (1) | EP0735890B1 (da) |
AT (1) | ATE216245T1 (da) |
AU (1) | AU1821295A (da) |
CA (1) | CA2179627C (da) |
DE (1) | DE69430440T2 (da) |
DK (1) | DK0735890T3 (da) |
ES (1) | ES2173948T3 (da) |
OA (1) | OA10721A (da) |
PT (1) | PT735890E (da) |
TW (1) | TW283645B (da) |
WO (1) | WO1995017899A2 (da) |
ZA (1) | ZA949219B (da) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US6346627B1 (en) | 1990-02-01 | 2002-02-12 | Emory University | Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers |
SE9003151D0 (sv) * | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
EP0610444B1 (en) | 1991-10-31 | 2003-01-29 | ELFORD, Howard L. | Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases |
ATE273700T1 (de) * | 1993-05-21 | 2004-09-15 | Us Gov Health & Human Serv | Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren |
US6677310B1 (en) * | 1999-04-21 | 2004-01-13 | Nabi | Ring-expanded nucleosides and nucleotides |
US6093702A (en) * | 1993-12-20 | 2000-07-25 | The United States Of America As Represented By The Department Of Health And Human Services | Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread |
US5521161A (en) * | 1993-12-20 | 1996-05-28 | Compagnie De Developpment Aguettant S.A. | Method of treating HIV in humans by administration of ddI and hydroxycarbamide |
AU688552B2 (en) * | 1994-07-15 | 1998-03-12 | Biosearch Italia S.P.A. | Dinucleoside-5',5'-pyrophosphates |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US5869493A (en) | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
US6511848B2 (en) * | 1996-04-17 | 2003-01-28 | Winfried Albert | Process for producing and multiplying lymphocytes |
US5719132A (en) * | 1996-06-27 | 1998-02-17 | Bristol-Myers Squibb Company | Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil |
US5886165A (en) * | 1996-09-24 | 1999-03-23 | Hybridon, Inc. | Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments |
US6218386B1 (en) | 1996-11-08 | 2001-04-17 | Dupont Pharmaceuticals | A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor |
US5932570A (en) * | 1996-11-08 | 1999-08-03 | Dupont Pharmaceuticals Company | 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors |
US6686462B2 (en) * | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
US6114312A (en) * | 1997-03-07 | 2000-09-05 | Research Institute For Genetic And Human Therapy (R.I.G.H.T.) | Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor |
CA2284483A1 (en) * | 1997-03-20 | 1998-10-01 | Compagnie De Developpement Aguettant | Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
WO1998050347A1 (en) * | 1997-05-05 | 1998-11-12 | The Regents Of The University Of California | Naphthols useful in antiviral methods |
AU9016998A (en) | 1997-08-08 | 1999-03-01 | Newbiotics, Inc. | Methods and compositions for overcoming resistance to biologic and chemotherapy |
US20020022034A1 (en) * | 1997-09-15 | 2002-02-21 | Julianna Lisziewicz | Therapeutic DNA vaccination |
KR100286373B1 (ko) * | 1997-10-17 | 2001-04-16 | 윤종용 | 적외선 데이터 통신을 위한 휴대용 컴퓨터 |
DK1045897T3 (da) | 1998-01-23 | 2002-05-13 | Newbiotics Inc | Enzymatisk katalyserede, terapeutiske midler |
US7462605B2 (en) * | 1998-01-23 | 2008-12-09 | Celmed Oncology (Usa), Inc. | Phosphoramidate compounds and methods of use |
US6015796A (en) * | 1998-03-11 | 2000-01-18 | Zeria Pharmaceutical Co., Ltd. | Method for treating AIDS |
US6251874B1 (en) * | 1998-03-26 | 2001-06-26 | Research Institute For Genetic And Human Therapy (R.I.G.H.T.) | Method of inhibiting human immunodeficiency virus using hydroxurea and a reverse transcriptase inhibitor in vivo |
MXPA00012842A (es) * | 1998-06-24 | 2004-06-22 | Univ Emory | Uso de 3'-azido-2',3'-didesoxiuridina en combinacion de drogas adicionales contra el vih para la manufactura de un medicamento para el tratamiento del vih. |
EP1146904A4 (en) * | 1999-02-03 | 2004-09-15 | Franco Lori | USE OF HYDROXY URINE AND AN INHIBITOR OF REVERSE TRANSCRIPTASE FOR INDUCING AUTOVACCATION BY AUTOLOGICAL HIV |
US6020325A (en) * | 1999-03-09 | 2000-02-01 | Zeria Pharmaceutical Co., Ltd. | Method for inhibiting replication of HIV |
WO2001007088A2 (en) | 1999-07-22 | 2001-02-01 | Newbiotics, Inc. | Methods for treating therapy-resistant tumors |
US6683061B1 (en) | 1999-07-22 | 2004-01-27 | Newbiotics, Inc. | Enzyme catalyzed therapeutic activation |
CA2380924C (en) | 1999-08-13 | 2008-02-19 | University Of Maryland Biotechnology Institute | Compositions for treating viral infections, and methods therefor |
NL1012825C2 (nl) * | 1999-08-13 | 2001-02-23 | Faculteit Geneeskunde Universi | Farmaceuticum voor de behandeling van virale infecties in het bijzonder van het humane immunodeficiency virus (HIV). |
WO2002056832A2 (en) * | 2001-01-19 | 2002-07-25 | Newbiotics, Inc. | Methods to treat autoimmune and inflammatory conditions |
US20050250728A1 (en) * | 2002-05-23 | 2005-11-10 | Shanta Bantia | Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
CA1314875C (en) * | 1985-05-15 | 1993-03-23 | George Walter Koszalka | Therapeutic nucleosides |
AU570853B2 (en) * | 1985-08-26 | 1988-03-24 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases |
US5110600A (en) * | 1988-01-25 | 1992-05-05 | The Regents Of The University Of California | Method of treating viral infections with amino acid analogs |
US5026687A (en) * | 1990-01-03 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds |
US5300059A (en) * | 1991-11-19 | 1994-04-05 | Hydro Slip Technologies Inc. | Bloodbag and method of making same |
ATE273700T1 (de) * | 1993-05-21 | 2004-09-15 | Us Gov Health & Human Serv | Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren |
US5521161A (en) * | 1993-12-20 | 1996-05-28 | Compagnie De Developpment Aguettant S.A. | Method of treating HIV in humans by administration of ddI and hydroxycarbamide |
-
1993
- 1993-12-20 US US08/169,253 patent/US5521161A/en not_active Expired - Lifetime
-
1994
- 1994-11-21 ZA ZA949219A patent/ZA949219B/xx unknown
- 1994-12-15 TW TW083111742A patent/TW283645B/zh active
- 1994-12-20 ES ES95909917T patent/ES2173948T3/es not_active Expired - Lifetime
- 1994-12-20 DE DE69430440T patent/DE69430440T2/de not_active Expired - Lifetime
- 1994-12-20 CA CA002179627A patent/CA2179627C/en not_active Expired - Fee Related
- 1994-12-20 PT PT95909917T patent/PT735890E/pt unknown
- 1994-12-20 AT AT95909917T patent/ATE216245T1/de not_active IP Right Cessation
- 1994-12-20 DK DK95909917T patent/DK0735890T3/da active
- 1994-12-20 AU AU18212/95A patent/AU1821295A/en not_active Abandoned
- 1994-12-20 WO PCT/IB1995/000153 patent/WO1995017899A2/en active IP Right Grant
- 1994-12-20 EP EP95909917A patent/EP0735890B1/en not_active Expired - Lifetime
-
1996
- 1996-03-18 US US08/617,421 patent/US5736527A/en not_active Expired - Lifetime
- 1996-06-20 OA OA60849A patent/OA10721A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA949219B (en) | 1995-08-01 |
WO1995017899A3 (en) | 1995-08-10 |
DE69430440D1 (de) | 2002-05-23 |
OA10721A (en) | 2002-12-09 |
US5521161A (en) | 1996-05-28 |
WO1995017899A2 (en) | 1995-07-06 |
ATE216245T1 (de) | 2002-05-15 |
EP0735890A1 (en) | 1996-10-09 |
DE69430440T2 (de) | 2002-11-14 |
CA2179627C (en) | 2000-02-22 |
TW283645B (da) | 1996-08-21 |
US5736527A (en) | 1998-04-07 |
AU1821295A (en) | 1995-07-17 |
ES2173948T3 (es) | 2002-11-01 |
EP0735890B1 (en) | 2002-04-17 |
PT735890E (pt) | 2002-09-30 |
CA2179627A1 (en) | 1995-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0735890T3 (da) | Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning | |
MY119031A (en) | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses | |
DE3587434T2 (de) | Antivirale pharmazeutische Zusammensetzungen und ihrer Verwendung. | |
BG60698B2 (en) | Pharmaceutical ACCEPTABLE SALTS | |
MX9700237A (es) | Combinaciones inhibidoras de proteasa retroviral. | |
DE69811062D1 (de) | Polyaromatische antivirale zusammensetzungen | |
DE69427704D1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane | |
GR3029370T3 (en) | Compounds and methods for inhibition of hiv and related viruses | |
BR9711647A (pt) | Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os. | |
ATE206916T1 (de) | Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen | |
DK153587A (da) | Forbindelser med nootrop virkning, midler indeholdende disse og deres anvendelse ved behandling af forebyggelse af cognitive dysfunktioner | |
ES2061811T3 (es) | Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera. | |
ATE158947T1 (de) | Hautregenerierende kosmetische zusammensetzung | |
MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. | |
NO20001758L (no) | FremgangsmÕter og blandinger for behandling av leddgikt | |
NO970573L (no) | Ylidenforbindelser og deres fremstilling | |
AU567018B2 (en) | Prazosin-pirbuterol combination for bronchoduation | |
DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
ES2153584T3 (es) | Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos. | |
ES2065855B1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
DE69614127D1 (de) | Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung | |
WO1995017875A3 (en) | MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD | |
MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. | |
GB9814039D0 (en) | Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury | |
DK381983A (da) | Fremgangsmaade til fremstilling af spiro(2h-1,4-benzodioxepin-3(5h)4'-piperidin- og -3'-pyrrolidinforbindelser |